Genetics of breast cancer: a topic in evolution von Shiovitz, S., Korde, L.A.

Volltext

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program von Cardoso, F., Bartlett, J.M.S., Slaets, L., van Deurzen, C.H.M., van Leeuwen-Stok, E., Porter, P., Linderholm, B., Hedenfalk, I., Schröder, C., Martens, J., Bayani, J., van Asperen, C., Murray, M., Hudis, C., Middleton, L., Vermeij, J., Punie, K., Fraser, J., Nowaczyk, M., Rubio, I.T., Aebi, S., Kelly, C., Ruddy, K.J., Winer, E., Nilsson, C., Lago, L. Dal, Korde, L., Benstead, K., Bogler, O., Goulioti, T., Peric, A., Litière, S., Aalders, K.C., Poncet, C., Tryfonidis, K., Giordano, S.H.

Volltext

Are we assuming too much with our statistical assumptions? Lessons learned from the ALTTO trial von Holmes, E.M., Bradbury, I., Williams, L.S., Korde, L., de Azambuja, E., Fumagalli, D., Moreno-Aspitia, A., Baselga, J., Piccart-Gebhart, M., Dueck, A.C., Gelber, R.D.

Volltext

Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives von Korde, L A, Premkumar, A, Mueller, C, Rosenberg, P, Soho, C, Bratslavsky, G, Greene, M H

Volltext

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Allia... von de Azambuja, E., Piccart-Gebhart, M., Fielding, S., Townend, J., Hillman, D.W., Colleoni, M., Roylance, R., Kelly, C.M., Lombard, J., El-Abed, S., Choudhury, A., Korde, L., Vicente, M., Chumsri, S., Rodeheffer, R., Ellard, S.L., Wolff, A.C., Holtschmidt, J., Lang, I., Untch, M., Boyle, F., Xu, B., Werutsky, G., Tujakowski, J., Huang, C.-S., Baruch, N.B., Bliss, J., Ferro, A., Gralow, J., Kim, S.-B., Kroep, J.R., Krop, I., Kuemmel, S., McConnell, R., Moscetti, L., Knop, A.S., van Duijnhoven, F., Gomez, H., Cameron, D., Di Cosimo, S., Gelber, R.D., Moreno-Aspitia, A.

Volltext

Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial von Mason, Caitlin, Xiao, Liren, Imayama, Ikuyo, Duggan, Catherine, Wang, Ching-Yun, Korde, Larissa, McTiernan, Anne

Volltext

Overall survival in the OlympiA phase Ill trial of adjuvant olaparib in patients with germime pathogenic variants in BRCA1/2 and high-risk, early breast cancer von Geyer, C. E., Garber, J. E., Gelber, R. D., Yothers, G., Taboada, M., Ross, L., Rastogi, P., Cui, K., Arahmani, A., Aktan, G., Armstrong, A. C., Arnedos, M., Balmana, J., Bergh, J., Bliss, J., Delaloge, S., Domchek, S. M., Eisen, A., Elsafy, F., Fein, L. E., Fielding, A., Ford, J. M., Friedman, S., Gelmon, K. A., Gianni, L., Gnant, M., Hollingsworth, S. J., Im, S. A., Jager, A., Lakhani, S. R., Janni, W., Linderholm, Barbro, Liu, T. W., Loman, N., Korde, L., Loibl, S., Lucas, P. C., Marme, F., de Duenas, E. M., McConnell, R., Phillips, K. A., Piccart, M., Rossi, G., Schmutzler, R., Senkus, E., Shao, Z., Sharma, P., Singer, C. F., Spanic, T., Stickeler, E., Toi, M., Traina, T. A., Viale, G., Zoppoli, G., Park, Y. H., Yerushalmi, R., Yang, H., Pang, D., Jung, K. H., Mailliez, A., Fan, Z., Tennevet, I., Zhang, J., Nagy, T., Sonke, G. S., Sun, Q., Parton, M., Colleoni, M. A., Schmidt, M., Brufsky, A. M., Razaq, W., Kaufman, B., Cameron, D., Campbell, C., Tutt, A. N. J., Johannsson, O. T.

Volltext

LBA48 Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIb-IV melanoma from SWOG S1801 von Patel, S., Othus, M., Wright, P., Hyngstrom, J., Lao, C.D., Truong, T-G., Chandra, S., Kendra, K., Devoe, C., Hegde, A., Mangla, A., Lowe, M., Buchbinder, E., Kirkwood, J.M., Sharon, E., Korde, L., Moon, J., Sondak, V.K., Ribas, A., Prieto, V.

Volltext

LBA6 Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801) von Patel, S., Othus, M., Prieto, V., Lowe, M., Buchbinder, E., Chen, Y., Hyngstrom, J., Lao, C.D., Truong, T-G., Chandra, S., Kendra, K., Devoe, C., Hedge, A., Mangla, A., Sharon, E., Korde, L., Moon, J., Sondak, V., Ribas, A.

Volltext

Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour von Kratz, Christian P, Han, Summer S, Rosenberg, Philip S, Berndt, Sonja I, Burdett, Laurie, Yeager, Meredith, Korde, Larissa A, Mai, Phuong L, Pfeiffer, Ruth, Greene, Mark H

Volltext

Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations von Korde, Larissa A, Zujewski, Jo Anne, Kamin, Leah, Giordano, Sharon, Domchek, Susan, Anderson, William F, Bartlett, John M S, Gelmon, Karen, Nahleh, Zeina, Bergh, Jonas, Cutuli, Bruno, Pruneri, Giancarlo, McCaskill-Stevens, Worta, Gralow, Julie, Hortobagyi, Gabriel, Cardoso, Fatima

Volltext

Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer—A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance T... von Symonds, Lynn, Linden, Hannah, Gadi, Vijayakrishna, Korde, Larissa, Rodler, Eve, Gralow, Julie, Redman, Mary, Baker, Kelsey, Wu, Quan (Vicky), Jenkins, Isaac, Kurland, Brenda, Garrison, Mitchell, Smith, Julie, Anderson, Jeanne, Van Haelst, Carol, Specht, Jennifer

Volltext

221P Long-term outcomes of patients with node-negative, ≤3cm, HER2+ breast cancer (BC) enrolled in ALTTO von Eiger, D., Tsourti, Z., Caparica, R., Kassapian, M., Napoleone, S., Hultsch, S., Korde, L., Wang, Y., Chumsri, S., Pritchard, K., Untch, M., Bellet Ezquerra, M., Rosa, D.D., Moreno-Aspitia, A., Piccart, M., Dafni, U., de Azambuja, E.

Volltext

199OLong-term cardiac outcomes of HER2+ breast cancer patients treated in the ALTTO trial von Eiger, D, Ponde, N F, Agbor-Tarh, D, Korde, L A, Moreno Aspitia, A, Rodeheffer, R J, Ewer, M, Suter, T, Piccart, M, de Azambuja, E

Volltext

Long-term cardiac outcomes of HER2+ breast cancer patients treated in the ALTTO trial von Eiger, D., Ponde, N.F., Agbor-Tarh, D., Korde, L.A., Moreno Aspitia, A., Rodeheffer, R.J., Ewer, M., Suter, T., Piccart, M., de Azambuja, E.

Volltext

Abstract OT1-02-04: SWOG S1418/NRG -BR006: A randomized, phase III trial to evaluate the efficacy and safety of MK-3475 as adjuvant therapy for triple receptor-negative breast canc... von Pusztai, L, Barlow, WE, Ganz, PA, Henry, NL, White, J, Jagsi, R, Mammen, JMV, Lew, D, Mejia, J, Karantza, V, Aktan, G, Sharon, E, Korde, L, Hortobagyi, GN, Mamounas, E

Volltext

Effects of vitamin D supplementation on lean mass, muscle strength, and bone mineral density during weight loss: A double-blind randomized controlled trial von Mason, C, Tapsoba, J D, Duggan, C, Imayama, I, Wang, CY, Korde, L, McTiernan, A

Volltext

Endogenous DNA damage and testicular germ cell tumors von Cook, M.B, Sigurdson, A.J, Jones, I.M, Thomas, C.B, Graubard, B.I, Korde, L, Greene, M.H, McGlynn, K.A

Volltext

Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients von Korde, Larissa A, Doody, David R, Hsu, Li, Porter, Peggy L, Malone, Kathleen E

Volltext

Abstract P1-15-02: Withdrawn von Schwab, R, Clark, A, Yau, C, Wolf, D, Chien, AJ, Majure, M, Ewing, C, Wallace, A, Roesch, E, Helsten, T, Forero, A, Stringer-Reasor, E, Vaklavas, C, Nanda, R, Jaskowiak, N, Boughey, J, Haddad, T, Han, H, Lee, C, Albain, K, Isaacs, C, Elias, A, Ellis, E, Shah, P, Lang, J, Lu, J, Tripathy, D, Kemmer, K, Yee, D, Haley, B, Korde, L, Edmiston, K, Northfelt, D, Viscusi, R, Khan, Q, Symmans, WF, Perlmutter, J, Hylton, N, Rugo, H, Melisko, M, Wilson, A, Singhrao, R, Asare, S, van't Veer, L, DeMichele, A, Berry, D, Esserman, L

Volltext